nodes	percent_of_prediction	percent_of_DWPC	metapath
Penciclovir—Herpes labialis—Epirubicin—bone cancer	0.0709	0.0709	CcSEcCtD
Penciclovir—Herpes labialis—Doxorubicin—bone cancer	0.0656	0.0656	CcSEcCtD
Penciclovir—Oral herpes—Epirubicin—bone cancer	0.0436	0.0436	CcSEcCtD
Penciclovir—Oral herpes—Doxorubicin—bone cancer	0.0404	0.0404	CcSEcCtD
Penciclovir—Leukocytoclastic vasculitis—Methotrexate—bone cancer	0.0224	0.0224	CcSEcCtD
Penciclovir—Pain—Carboplatin—bone cancer	0.0208	0.0208	CcSEcCtD
Penciclovir—Parosmia—Epirubicin—bone cancer	0.0159	0.0159	CcSEcCtD
Penciclovir—Renal failure acute—Cisplatin—bone cancer	0.0157	0.0157	CcSEcCtD
Penciclovir—Parosmia—Doxorubicin—bone cancer	0.0147	0.0147	CcSEcCtD
Penciclovir—Rash erythematous—Epirubicin—bone cancer	0.0134	0.0134	CcSEcCtD
Penciclovir—Rash erythematous—Doxorubicin—bone cancer	0.0124	0.0124	CcSEcCtD
Penciclovir—Skin discolouration—Methotrexate—bone cancer	0.0122	0.0122	CcSEcCtD
Penciclovir—Delirium—Epirubicin—bone cancer	0.012	0.012	CcSEcCtD
Penciclovir—Jaundice cholestatic—Epirubicin—bone cancer	0.0117	0.0117	CcSEcCtD
Penciclovir—Skin discolouration—Epirubicin—bone cancer	0.0114	0.0114	CcSEcCtD
Penciclovir—Delirium—Doxorubicin—bone cancer	0.0111	0.0111	CcSEcCtD
Penciclovir—Jaundice cholestatic—Doxorubicin—bone cancer	0.0108	0.0108	CcSEcCtD
Penciclovir—Hepatobiliary disease—Cisplatin—bone cancer	0.0106	0.0106	CcSEcCtD
Penciclovir—Skin discolouration—Doxorubicin—bone cancer	0.0105	0.0105	CcSEcCtD
Penciclovir—Cardiac disorder—Cisplatin—bone cancer	0.00933	0.00933	CcSEcCtD
Penciclovir—Erythema—Cisplatin—bone cancer	0.00875	0.00875	CcSEcCtD
Penciclovir—Renal failure acute—Methotrexate—bone cancer	0.00864	0.00864	CcSEcCtD
Penciclovir—Flatulence—Cisplatin—bone cancer	0.00863	0.00863	CcSEcCtD
Penciclovir—Anaemia—Cisplatin—bone cancer	0.00809	0.00809	CcSEcCtD
Penciclovir—Renal failure acute—Epirubicin—bone cancer	0.00808	0.00808	CcSEcCtD
Penciclovir—Leukopenia—Cisplatin—bone cancer	0.00783	0.00783	CcSEcCtD
Penciclovir—Renal failure acute—Doxorubicin—bone cancer	0.00748	0.00748	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.0074	0.0074	CcSEcCtD
Penciclovir—Liver function test abnormal—Methotrexate—bone cancer	0.00736	0.00736	CcSEcCtD
Penciclovir—Migraine—Epirubicin—bone cancer	0.00735	0.00735	CcSEcCtD
Penciclovir—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00718	0.00718	CcSEcCtD
Penciclovir—Nervous system disorder—Cisplatin—bone cancer	0.00701	0.00701	CcSEcCtD
Penciclovir—Thrombocytopenia—Cisplatin—bone cancer	0.00699	0.00699	CcSEcCtD
Penciclovir—Skin disorder—Cisplatin—bone cancer	0.00694	0.00694	CcSEcCtD
Penciclovir—Liver function test abnormal—Epirubicin—bone cancer	0.00689	0.00689	CcSEcCtD
Penciclovir—Migraine—Doxorubicin—bone cancer	0.0068	0.0068	CcSEcCtD
Penciclovir—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00672	0.00672	CcSEcCtD
Penciclovir—Neutropenia—Methotrexate—bone cancer	0.00645	0.00645	CcSEcCtD
Penciclovir—Paraesthesia—Cisplatin—bone cancer	0.00641	0.00641	CcSEcCtD
Penciclovir—Liver function test abnormal—Doxorubicin—bone cancer	0.00638	0.00638	CcSEcCtD
Penciclovir—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00622	0.00622	CcSEcCtD
Penciclovir—Pain—Cisplatin—bone cancer	0.00611	0.00611	CcSEcCtD
Penciclovir—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00609	0.00609	CcSEcCtD
Penciclovir—Neutropenia—Epirubicin—bone cancer	0.00603	0.00603	CcSEcCtD
Penciclovir—Feeling abnormal—Cisplatin—bone cancer	0.00589	0.00589	CcSEcCtD
Penciclovir—Hepatobiliary disease—Methotrexate—bone cancer	0.00581	0.00581	CcSEcCtD
Penciclovir—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.0057	0.0057	CcSEcCtD
Penciclovir—Neutropenia—Doxorubicin—bone cancer	0.00558	0.00558	CcSEcCtD
Penciclovir—Hepatobiliary disease—Epirubicin—bone cancer	0.00544	0.00544	CcSEcCtD
Penciclovir—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00528	0.00528	CcSEcCtD
Penciclovir—Hypersensitivity—Cisplatin—bone cancer	0.00526	0.00526	CcSEcCtD
Penciclovir—Erythema multiforme—Methotrexate—bone cancer	0.00522	0.00522	CcSEcCtD
Penciclovir—Hypoaesthesia—Epirubicin—bone cancer	0.00514	0.00514	CcSEcCtD
Penciclovir—Asthenia—Cisplatin—bone cancer	0.00513	0.00513	CcSEcCtD
Penciclovir—Cardiac disorder—Methotrexate—bone cancer	0.00512	0.00512	CcSEcCtD
Penciclovir—Hepatobiliary disease—Doxorubicin—bone cancer	0.00503	0.00503	CcSEcCtD
Penciclovir—Diarrhoea—Cisplatin—bone cancer	0.00489	0.00489	CcSEcCtD
Penciclovir—Erythema multiforme—Epirubicin—bone cancer	0.00488	0.00488	CcSEcCtD
Penciclovir—Mental disorder—Methotrexate—bone cancer	0.00483	0.00483	CcSEcCtD
Penciclovir—Erythema—Methotrexate—bone cancer	0.0048	0.0048	CcSEcCtD
Penciclovir—Cardiac disorder—Epirubicin—bone cancer	0.00479	0.00479	CcSEcCtD
Penciclovir—Hypoaesthesia—Doxorubicin—bone cancer	0.00475	0.00475	CcSEcCtD
Penciclovir—Dysgeusia—Methotrexate—bone cancer	0.0047	0.0047	CcSEcCtD
Penciclovir—Vomiting—Cisplatin—bone cancer	0.00454	0.00454	CcSEcCtD
Penciclovir—Mental disorder—Epirubicin—bone cancer	0.00452	0.00452	CcSEcCtD
Penciclovir—Erythema multiforme—Doxorubicin—bone cancer	0.00452	0.00452	CcSEcCtD
Penciclovir—Rash—Cisplatin—bone cancer	0.0045	0.0045	CcSEcCtD
Penciclovir—Dermatitis—Cisplatin—bone cancer	0.0045	0.0045	CcSEcCtD
Penciclovir—Erythema—Epirubicin—bone cancer	0.00449	0.00449	CcSEcCtD
Penciclovir—Anaemia—Methotrexate—bone cancer	0.00444	0.00444	CcSEcCtD
Penciclovir—Cardiac disorder—Doxorubicin—bone cancer	0.00443	0.00443	CcSEcCtD
Penciclovir—Flatulence—Epirubicin—bone cancer	0.00443	0.00443	CcSEcCtD
Penciclovir—Dysgeusia—Epirubicin—bone cancer	0.0044	0.0044	CcSEcCtD
Penciclovir—Leukopenia—Methotrexate—bone cancer	0.0043	0.0043	CcSEcCtD
Penciclovir—Nausea—Cisplatin—bone cancer	0.00424	0.00424	CcSEcCtD
Penciclovir—Mental disorder—Doxorubicin—bone cancer	0.00419	0.00419	CcSEcCtD
Penciclovir—Erythema—Doxorubicin—bone cancer	0.00416	0.00416	CcSEcCtD
Penciclovir—Anaemia—Epirubicin—bone cancer	0.00415	0.00415	CcSEcCtD
Penciclovir—Flatulence—Doxorubicin—bone cancer	0.0041	0.0041	CcSEcCtD
Penciclovir—Dysgeusia—Doxorubicin—bone cancer	0.00407	0.00407	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00406	0.00406	CcSEcCtD
Penciclovir—Leukopenia—Epirubicin—bone cancer	0.00402	0.00402	CcSEcCtD
Penciclovir—Palpitations—Epirubicin—bone cancer	0.00397	0.00397	CcSEcCtD
Penciclovir—Confusional state—Methotrexate—bone cancer	0.00395	0.00395	CcSEcCtD
Penciclovir—Nervous system disorder—Methotrexate—bone cancer	0.00384	0.00384	CcSEcCtD
Penciclovir—Anaemia—Doxorubicin—bone cancer	0.00384	0.00384	CcSEcCtD
Penciclovir—Thrombocytopenia—Methotrexate—bone cancer	0.00384	0.00384	CcSEcCtD
Penciclovir—Skin disorder—Methotrexate—bone cancer	0.00381	0.00381	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.0038	0.0038	CcSEcCtD
Penciclovir—Leukopenia—Doxorubicin—bone cancer	0.00372	0.00372	CcSEcCtD
Penciclovir—Confusional state—Epirubicin—bone cancer	0.0037	0.0037	CcSEcCtD
Penciclovir—Palpitations—Doxorubicin—bone cancer	0.00368	0.00368	CcSEcCtD
Penciclovir—Nervous system disorder—Epirubicin—bone cancer	0.0036	0.0036	CcSEcCtD
Penciclovir—Thrombocytopenia—Epirubicin—bone cancer	0.00359	0.00359	CcSEcCtD
Penciclovir—Skin disorder—Epirubicin—bone cancer	0.00356	0.00356	CcSEcCtD
Penciclovir—Paraesthesia—Methotrexate—bone cancer	0.00352	0.00352	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00352	0.00352	CcSEcCtD
Penciclovir—Somnolence—Methotrexate—bone cancer	0.00348	0.00348	CcSEcCtD
Penciclovir—Confusional state—Doxorubicin—bone cancer	0.00342	0.00342	CcSEcCtD
Penciclovir—Fatigue—Methotrexate—bone cancer	0.00338	0.00338	CcSEcCtD
Penciclovir—Pain—Methotrexate—bone cancer	0.00335	0.00335	CcSEcCtD
Penciclovir—Nervous system disorder—Doxorubicin—bone cancer	0.00333	0.00333	CcSEcCtD
Penciclovir—Thrombocytopenia—Doxorubicin—bone cancer	0.00332	0.00332	CcSEcCtD
Penciclovir—Skin disorder—Doxorubicin—bone cancer	0.0033	0.0033	CcSEcCtD
Penciclovir—Paraesthesia—Epirubicin—bone cancer	0.00329	0.00329	CcSEcCtD
Penciclovir—Somnolence—Epirubicin—bone cancer	0.00326	0.00326	CcSEcCtD
Penciclovir—Feeling abnormal—Methotrexate—bone cancer	0.00323	0.00323	CcSEcCtD
Penciclovir—Gastrointestinal pain—Methotrexate—bone cancer	0.00321	0.00321	CcSEcCtD
Penciclovir—Fatigue—Epirubicin—bone cancer	0.00316	0.00316	CcSEcCtD
Penciclovir—Pain—Epirubicin—bone cancer	0.00314	0.00314	CcSEcCtD
Penciclovir—Urticaria—Methotrexate—bone cancer	0.00311	0.00311	CcSEcCtD
Penciclovir—Abdominal pain—Methotrexate—bone cancer	0.0031	0.0031	CcSEcCtD
Penciclovir—Paraesthesia—Doxorubicin—bone cancer	0.00305	0.00305	CcSEcCtD
Penciclovir—Feeling abnormal—Epirubicin—bone cancer	0.00302	0.00302	CcSEcCtD
Penciclovir—Somnolence—Doxorubicin—bone cancer	0.00302	0.00302	CcSEcCtD
Penciclovir—Gastrointestinal pain—Epirubicin—bone cancer	0.003	0.003	CcSEcCtD
Penciclovir—Fatigue—Doxorubicin—bone cancer	0.00293	0.00293	CcSEcCtD
Penciclovir—Urticaria—Epirubicin—bone cancer	0.00291	0.00291	CcSEcCtD
Penciclovir—Pain—Doxorubicin—bone cancer	0.0029	0.0029	CcSEcCtD
Penciclovir—Abdominal pain—Epirubicin—bone cancer	0.0029	0.0029	CcSEcCtD
Penciclovir—Hypersensitivity—Methotrexate—bone cancer	0.00289	0.00289	CcSEcCtD
Penciclovir—Asthenia—Methotrexate—bone cancer	0.00281	0.00281	CcSEcCtD
Penciclovir—Feeling abnormal—Doxorubicin—bone cancer	0.0028	0.0028	CcSEcCtD
Penciclovir—Gastrointestinal pain—Doxorubicin—bone cancer	0.00278	0.00278	CcSEcCtD
Penciclovir—Pruritus—Methotrexate—bone cancer	0.00277	0.00277	CcSEcCtD
Penciclovir—Hypersensitivity—Epirubicin—bone cancer	0.0027	0.0027	CcSEcCtD
Penciclovir—Urticaria—Doxorubicin—bone cancer	0.0027	0.0027	CcSEcCtD
Penciclovir—Abdominal pain—Doxorubicin—bone cancer	0.00268	0.00268	CcSEcCtD
Penciclovir—Diarrhoea—Methotrexate—bone cancer	0.00268	0.00268	CcSEcCtD
Penciclovir—Asthenia—Epirubicin—bone cancer	0.00263	0.00263	CcSEcCtD
Penciclovir—Pruritus—Epirubicin—bone cancer	0.0026	0.0026	CcSEcCtD
Penciclovir—Dizziness—Methotrexate—bone cancer	0.00259	0.00259	CcSEcCtD
Penciclovir—Diarrhoea—Epirubicin—bone cancer	0.00251	0.00251	CcSEcCtD
Penciclovir—Hypersensitivity—Doxorubicin—bone cancer	0.0025	0.0025	CcSEcCtD
Penciclovir—Vomiting—Methotrexate—bone cancer	0.00249	0.00249	CcSEcCtD
Penciclovir—Rash—Methotrexate—bone cancer	0.00247	0.00247	CcSEcCtD
Penciclovir—Dermatitis—Methotrexate—bone cancer	0.00247	0.00247	CcSEcCtD
Penciclovir—Headache—Methotrexate—bone cancer	0.00246	0.00246	CcSEcCtD
Penciclovir—Asthenia—Doxorubicin—bone cancer	0.00244	0.00244	CcSEcCtD
Penciclovir—Dizziness—Epirubicin—bone cancer	0.00243	0.00243	CcSEcCtD
Penciclovir—Pruritus—Doxorubicin—bone cancer	0.0024	0.0024	CcSEcCtD
Penciclovir—Vomiting—Epirubicin—bone cancer	0.00233	0.00233	CcSEcCtD
Penciclovir—Nausea—Methotrexate—bone cancer	0.00233	0.00233	CcSEcCtD
Penciclovir—Diarrhoea—Doxorubicin—bone cancer	0.00232	0.00232	CcSEcCtD
Penciclovir—Rash—Epirubicin—bone cancer	0.00231	0.00231	CcSEcCtD
Penciclovir—Dermatitis—Epirubicin—bone cancer	0.00231	0.00231	CcSEcCtD
Penciclovir—Headache—Epirubicin—bone cancer	0.0023	0.0023	CcSEcCtD
Penciclovir—Dizziness—Doxorubicin—bone cancer	0.00224	0.00224	CcSEcCtD
Penciclovir—Nausea—Epirubicin—bone cancer	0.00218	0.00218	CcSEcCtD
Penciclovir—Vomiting—Doxorubicin—bone cancer	0.00216	0.00216	CcSEcCtD
Penciclovir—Rash—Doxorubicin—bone cancer	0.00214	0.00214	CcSEcCtD
Penciclovir—Dermatitis—Doxorubicin—bone cancer	0.00214	0.00214	CcSEcCtD
Penciclovir—Headache—Doxorubicin—bone cancer	0.00213	0.00213	CcSEcCtD
Penciclovir—Nausea—Doxorubicin—bone cancer	0.00202	0.00202	CcSEcCtD
